Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply
TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.
With the close of the transaction, Bora Group's biologics CDMO franchise, Bora Biologics, now operates 20,000 liters of single-use bioreactor (SUB) drug substance manufacturing capacity across two active US sites: Rockville, Maryland and San Diego, California, and one development facility in Zhubei, Taiwan.
"This acquisition establishes a US biologics manufacturing platform that sponsors can depend on, from development through licensed commercial supply," said Bobby Sheng, Chairman and CEO of Bora Group. "As regulatory and supply chain dynamics continue to evolve, we expect biotech and pharmaceutical companies to increasingly seek manufacturing partners with US-based, inspection-proven infrastructure. Bora Biologics is designed to meet that need, offering a fully integrated, end-to-end biologics platform spanning drug substance and drug product capabilities."
With the addition of the Rockville facility, Bora Biologics supports more than 4 active commercial programs, with more than 120 completed GMP batches and supply into multiple global markets including the US, EU, Japan, Canada and the UK with fully integrated QC and analytical capabilities.
Across its US network, Bora Biologics has completed five FDA inspections, including two at Rockville and one PMDA review in 2025, with clean results at both sites. The combined platform has supported more than 33 biologics and 15 biosimilars, establishing a manufacturing base for biotech and pharmaceutical companies with reduced offshore dependency and domestically anchored infrastructure.
Bora Group intends to integrate its US drug substance (DS) capabilities with its existing sterile drug product (DP) capabilities over the next 12 to 18 months, offering a seamless, fully integrated development-through-commercial biologics solution.
Hashtag: #BoraPharmaceuticals
The issuer is solely responsible for the content of this announcement.
About Bora
Founded in 2007, Bora Pharmaceuticals ("Bora" or "the Company", 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of "Contributing to Better Health All Over the World". Operating under a "Dual Engine" model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients' quality of life.
By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success "certain," Bora sets new standards in the pharmaceutical and CDMO industries.
For more, please visit:
https://www.bora-corp.com
https://www.boracdmo.com
Disclaimer:
This document and the accompanying information may contain forward-looking statements. All statements regarding the company's future business operations, potential events, and prospects (including but not limited to forecasts, targets, estimates, and operational plans) are considered forward-looking statements unless they refer to factual occurrences. Forward-looking statements are subject to various factors and uncertainties that may cause significant differences from actual results, including but not limited to price fluctuations, actual demand, exchange rate variations, market share, competitive conditions, changes in the legal, financial, and regulatory framework, international economic and financial market conditions, political risks, cost estimates, and other risks and variables beyond the company's control. These forward-looking statements are based on current predictions and assessments, and the company disclaims any responsibility for future updates.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
Singapore-based companies have committed more than S$5.5 billion in Johor since the JS-SEZ memorandum of understanding, while IMFC-J reported 1,000 enquiries linked to RM73 billion in potential investment in March 2026.
JOHOR, MALAYSIA - Media OutReach Newswire - 2 July 2026 - Forest City Special Financial Zone (Forest City SFZ) today issued a progress update on the Johor-Singapore Special Economic Zone (JS-SEZ), pointing to early implementation milestones in investment facilitation, financial-services incentives and cross-border connectivity.
The JS-SEZ agreement, signed on 7 January 2025, covers approximately 3,588 square kilometres across southern Johor. It comprises nine flagship areas and targets investment in 11 sectors, including manufacturing, logistics, financial services, the digital economy, tourism, education, healthcare and the green economy. Forest City is the designated financial-services flagship within the framework.
"The JS-SEZ has moved beyond framework design and into early-stage execution. Forest City has a defined role in financial services and family-office activity, while the wider zone is building a pipeline across multiple industries," a Forest City SFZ spokesperson said.
Investment pipeline builds across the JS-SEZ
Singapore's Ministry of Trade and Industry said Singapore-based companies had committed more than S$5.5 billion in investments into Johor since the JS-SEZ memorandum of understanding was signed in January 2024. The figure was highlighted at the second JS-SEZ Joint Investment Forum in Singapore in October 2025.
On the Malaysian side, the Invest Malaysia Facilitation Centre Johor (IMFC-J) reported in March 2026 that it had received 1,000 investor enquiries and was facilitating RM73 billion in potential investment.
IMFC-J is a joint federal-state one-stop centre led by the Iskandar Regional Development Authority, Invest Johor and the Malaysian Investment Development Authority.
The figures represent investment commitments and potential project value rather than fully realised capital expenditure, but provide an early measure of the commercial pipeline forming around the economic corridor.
Forest City builds financial-services proposition
Malaysia announced the Forest City SFZ incentive package in September 2024, followed by the gazettement of the Single Family Office (SFO) tax rules in October 2025. Under the scheme, a qualifying SFO vehicle may receive a 0% tax rate on eligible investment income for an initial 10-year period, with a possible extension for a further 10 years, subject to asset, local investment, staffing and operating-expenditure requirements.
The initial phase requires at least RM30 million in assets under management. The wider Forest City incentive framework also includes a 5% corporate tax rate for qualifying global-services and selected relocation activities, while eligible knowledge workers in the JS-SEZ may qualify for a 15% personal income tax rate, subject to prevailing rules and approvals.
According to Forest City data, nine family offices had received approvals under the scheme by June 2026. The Securities Commission Malaysia had previously reported more than 30 expressions of interest and has set a target of RM2 billion in SFO assets under management by the end of 2026.
Separately, Forest City said 593 applicants were approved for the SFZ category of the Malaysia My Second Home programme between 1 October 2024 and 31 March 2026, indicating demand from investors, professionals and long-stay residents alongside the financial-services push.
Cross-border measures support the dual-market model
The JS-SEZ framework is intended to combine Johor's land, industrial capacity and cost base with Singapore's capital, connectivity and business ecosystem. Measures under the bilateral framework include investor facilitation, automated immigration channels, paperless goods clearance and improved transport links.
Singapore has rolled out QR-code immigration clearance across travel modes at the Woodlands and Tuas checkpoints. Travellers should continue to carry their passports, which may still be required for verification and for clearance at the Malaysian border.
The Johor Bahru-Singapore Rapid Transit System Link is targeted to begin passenger service by the end of 2026. The four-kilometre line will connect Bukit Chagar and Woodlands North in about five minutes and is designed to carry up to 10,000 passengers per hour in each direction during peak periods.
Execution and conversion remain the next test
The World Bank projects Malaysia's economy to expand by 4.4% in 2026, supported by domestic demand, while warning that trade restrictions, global policy uncertainty and weaker external demand remain downside risks.
For the JS-SEZ, the next phase will be measured by the conversion of enquiries and commitments into approved projects, realised investment, skilled employment and operating businesses. Delivery of transport, utilities, talent development and regulatory coordination will also determine the pace at which companies adopt a cross-border operating model.
"The early indicators are encouraging, but the economic impact should be assessed over a multi-year horizon. The priority now is to convert the pipeline into sustainable business activity, jobs and a deeper professional-services ecosystem," the spokesperson said.
Forest City SFZ said it will continue working with public agencies, financial institutions and professional-service providers to support family offices, international investors and companies evaluating Johor as part of their regional growth strategy.
Key figures
| Indicator | Latest stated figure |
| JS-SEZ coverage | Approximately 3,588 km²; nine flagship areas; 11 priority sectors |
| Singapore-linked commitments | More than S$5.5 billion committed into Johor since January 2024 |
| IMFC-J pipeline | 1,000 enquiries; RM73 billion in potential investment as at March 2026 |
| SFO incentive | 0% on eligible investment income for 10 years, with a possible further 10 years |
| RTS Link | Targeted passenger service by end-2026; up to 10,000 passengers per hour per direction |
| Malaysia 2026 GDP outlook | 4.4% growth forecast by the World Bank |
Hashtag: #ForestCity
The issuer is solely responsible for the content of this announcement.
About Forest City Special Financial Zone
Located in Iskandar Puteri, Johor, Forest City Special Financial Zone (FCSFZ) is Malaysia's pioneering special financial zone and the financial-services flagship within the Johor–Singapore Special Economic Zone. It is positioned to attract financial institutions, multinational corporations, high-net-worth individuals and businesses operating in wealth management, financial technology and global business services.
Its incentive framework includes a 0% income tax rate for qualifying Single Family Office Vehicles for up to 20 years, a preferential 5% corporate tax rate for approved qualifying activities, and a special 15% personal income tax rate for eligible knowledge workers, subject to the applicable conditions, regulatory approvals and prevailing legislation. Forest City also holds duty-free island status, further strengthening its appeal as a regional investment, business and wealth-management destination near Singapore.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
Forest City, Johor
